One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

FDA Approves Non-Opioid Treatment for Moderate to Severe Acute Pain as Agency Continues to Take Steps to Support New ...

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

More than 81,000 people in 2023 died in overdoses that involved opioids, according to federal data. According to the FDA, Journavx “reduces pain by targeting a pain-signaling pathway involving ...